Mariyam Zuberi

New Delhi, DL 110002, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors.

Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 03, 2023

Inhibition of RAS-driven signaling and tumorigenesis with a pan-RAS monobody targeting the Switch I/II pocket.

Inhibition of RAS-driven signaling and tumorigenesis with a pan-RAS monobody targeting the Switch I/II pocket.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 17, 2022

Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.

Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.

Journal: Cell reports

Published: July 30, 2021

Targeting the KRAS α4-α5 allosteric interface inhibits pancreatic cancer tumorigenesis.

Targeting the KRAS α4-α5 allosteric interface inhibits pancreatic cancer tumorigenesis.

Journal: Small GTPases

Published: May 05, 2021

Correction to: Ectopic PD-L1 expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated via increased activation of STAT3 and STAT5.

Correction to: Ectopic PD-L1 expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated via increased activation of STAT3 and STAT5.

Journal: Human cell

Published: July 16, 2020

Inhibition of RAS: proven and potential vulnerabilities.

Inhibition of RAS: proven and potential vulnerabilities.

Journal: Biochemical Society transactions

Published: July 06, 2020

Epigenetic Silencing of DAPK1and p16 INK4a Genes by CpG Island Hypermethylation in Epithelial Ovarian Cancer Patients.

Epigenetic Silencing of DAPK1and p16 INK4a Genes by CpG Island Hypermethylation in Epithelial Ovarian Cancer Patients.

Journal: Indian journal of clinical biochemistry : IJCB

Published: April 07, 2020

Ectopic PD-L1 expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated via increased activation of STAT3 and STAT5.

Ectopic PD-L1 expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated via increased activation of STAT3 and STAT5.

Journal: Human cell

Published: January 27, 2020

The Promising Signatures of Circulating microRNA-145 in Epithelial Ovarian Cancer Patients.

The Promising Signatures of Circulating microRNA-145 in Epithelial Ovarian Cancer Patients.

Journal: MicroRNA (Shariqah, United Arab Emirates)

Published: October 02, 2018

Association of GABAA Receptor Gene with Epilepsy Syndromes.

Association of GABAA Receptor Gene with Epilepsy Syndromes.

Journal: Journal of molecular neuroscience : MN

Published: March 09, 2018

PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India.

PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: October 12, 2017

A deletion polymorphism in the RIZ gene is associated with increased progression of imatinib treated chronic myeloid leukemia patients.

A deletion polymorphism in the RIZ gene is associated with increased progression of imatinib treated chronic myeloid leukemia patients.

Journal: Leukemia & lymphoma

Published: November 11, 2016

Showing 1-12 of 23

Last Updated: 09/26/2026